BIVATUZUMAB
UNII 0A0Z1IJN86

Substance Identification & Data

This profile provides standardized clinical and technical data for Bivatuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 0A0Z1IJN86.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 214559-60-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
0A0Z1IJN86
CAS Registry Number
214559-60-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BIVATUZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C175749
National Cancer Institute reference terminology for clinical and research data.
INN ID
7965
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bivatuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BIVATUZUMAB

Common Names & Synonyms

BIVATUZUMAB [INN]

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD44V6 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL BIWA4 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL BIWA4 .KAPPA.-CHAIN, DIMER

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus